Completion imaging after carotid endarterectomy in the Vascular Study Group of New England  by Wallaert, Jessica B. et al.
From the New England Society for Vascular Surgery
Completion imaging after carotid endarterectomy
in the Vascular Study Group of New England
Jessica B. Wallaert, MD,a Philip P. Goodney, MD, MS,a John J. Vignati, MD,b David H. Stone, MD,a
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Objectives: We studied surgeons’ practice patterns in the use of completion imaging (duplex or arteriography), and their
association with 30-day stroke/death and 1-year restenosis after carotid endarterectomy (CEA).
Methods: Using a retrospective analysis of 6115 CEAs, we categorized surgeons based on use of completion imaging as
rarely (<5% of CEAs), selective (5% to 90%), or routine (>90%). Crude and risk-adjusted 30-day stroke/death and 1-year
restenosis rates were examined across surgeon practice patterns. Finally, we audited 90 operative reports of patients who
underwent re-exploration and characterized findings and interventions. We analyzed the effect of re-exploration on
outcomes.
Results: Practice patterns in completion imaging varied: 51% of surgeons performed completion imaging rarely, 22%
selectively, and 27% routinely. Crude 30-day stroke/death rates were highest among surgeons who routinely used
completion imaging (rarely: 1.7%; selectively: 1.2%, routinely: 2.4%; P  .05). However, after adjusting for patient
characteristics predictive of stroke/death, the effect of surgeon practice pattern was not statistically significant (odds ratio
[OR] for routine-use surgeons, 1.42; 95% CI, 0.93-2.17; P  .10; selective-use surgeons, 0.75; 95% CI, 0.40-1.41; P 
.366). Stenosis >70% at 1 year showed a trend toward lowest rates for surgeons who performed completion imaging
(rarely: 2.8%, selectively: 1.1%, and routinely: 1.1%; P  .09). This effect became statistically significant for selective-use
surgeons after adjustment (hazard risk [HR] for selective-use surgeons, 0.52; 95% CI, 0.29-0.92; P .02). Overall, 178
patients (2.9%) underwent operative re-exploration. Routine-use surgeons were most likely to perform re-exploration
(7.6% routine, 0.8% selective, 0.9% rare; P< .001). An audit of 90 re-explored patients demonstrated technical problems,
the most common being flap, debris, and plaque. Rates of stroke/death were higher among patients who underwent
re-exploration (3.9% vs 1.7%; P  .03); however, this affect was attenuated after adjustment (OR, 2.1; 95% CI, 0.9-5.0;
P  .08).
Conclusions: The use of completion imaging during CEA varies widely across our region. There is little evidence that
surgeons who use completion imaging have lower rates of 30-day stroke/death, although selective use of completion
imaging is associated with a small but a significant reduction in stenosis 1 year after surgery. We also demonstrate an
association between re-exploration and higher risk of 30-day stroke/death, although this effect was attenuated after
adjustment for patient-level predictors of stroke/death. Future work is needed to direct the selective use of completion
imaging to prevent stroke, rather than cause unnecessary re-exploration. (J Vasc Surg 2011;54:376-85.)
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imaging to ensure a technically sound operation during
carotid endarterectomy (CEA).1-10 Proponents argue that
completion imaging allows surgeons to identify causes of
and avert early complications, as well as to ensure good
long-term outcomes by avoiding restenosis.1-8,11,12 Com-
pletion imaging with arteriography3,4,9,10 and duplex ultra-
sound1-13 have been studied extensively and have excellent
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376ensitivity (97% to 100%) and specificity (100%)5,14 for the
ntraoperative detection of technical errors during CEA.
Despite evidence that completion imaging can effec-
ively detect technical problems during CEA, the true
tility of completion imaging remains a topic of debate.9,15
t is unclear if completion imaging is routinely necessary,
hich abnormalities require re-exploration, and what effect
ompletion imaging has on outcomes such as 30-day
troke/death or restenosis.4,7-9,15 Studies attempting to
nswer these questions have largely consisted of small,
ingle-center series,1-8,11,12 or were not adequately pow-
red to detect differences in outcomes.2-7,11,12
Moreover, although proof that completion imaging is
elpful has been difficult to establish, some have suggested
hat it may be harmful.9,15 For example, defects of uncer-
ain significance detected on completion imaging might
ead to complications caused by unnecessary surgical re-
xploration. A recent literature review suggested that ap-
roximately 10% of patients who undergo completion im-
ging are re-explored at the time of surgery,1-8,10-13,16-25
otentially unnecessarily increasing the risk of stroke or
echnical complications.1-8,11-13
d
c
s
u
o
o
a
f
n
n
a
e
p
p
r
4
a
d
3

s
s
t
t
a
ter ca
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 2 Wallaert et al 377The purpose of this study was to describe the use of
completion imaging in our region, and its effect on out-
comes after CEA. Using different surgeon practice patterns
in the use of completion imaging as our exposure variable,
we studied the associations between completion imaging
and 30-day stroke/death, as well as restenosis1 year after
surgery.
METHODS
Patients and databases. For this report, we used data
collected by the Vascular Study Group of New England
(VSGNE), a regional cooperative quality improvement ini-
tiative developed to improve vascular health care. Further
details on the registry used by VSGNE have been published
previously26 and are available at http://www.vsgne.org.
Data were examined from 6379 CEAs performed in
5638 patients who underwent CEA by 73 participating
surgeons across 11 study hospitals, between January 2003
and January 2010. Of these, we excluded 118 CEAs done
concomitantly during coronary bypass grafting and 146
redo CEAs. This left 6115 primary, isolated CEAs in our
cohort for analysis.
Completion imaging. Cases involving the use of
completion imaging (defined as duplex ultrasound or con-
trast arteriography) were identified in the VSGNE data set.
Completion imaging, interpretation, and decision making
regarding potential carotid artery re-exploration was per-
formed at the discretion of the operating surgeon and was
not controlled by any research protocol.
Defining surgeon practice patterns. Based on the
Fig 1. Variation in completion imaging use afuse of completion imaging by individual surgeons in our vata set (Fig 1), as well as by a literature review,9 we
ategorized surgeon practice patterns as rare (5% of a
urgeon’s CEAs), selective (5% to 90%) or routine (90%)
se of completion imaging. We then evaluated patient
utcomes after CEA across each of the three groups.
Main outcome measures. Our study had two main
utcome measures: 30-day postoperative stroke/death,
nd 70% stenosis of the ipsilateral carotid artery at 1-year
ollow-up. Major stroke was defined as disability causing
on-independent living status; minor stroke was defined as
ondisabling.
For our second main outcome measure,70% restenosis
t 1-year, we studied only patientswhohadundergone duplex
valuation of their CEA at 1 year. Because not all of the
atients who underwent CEA procedures in 2009 have com-
leted follow-up, these procedures were excluded from the
estenosis analyses (1116 of 6115; 18%). Of the remaining
999 patients, 858 (17%) were lost to follow-up, and an
dditional 350 (7%)were excluded from analyses because they
id not undergo duplex imaging at their follow-up. This left
791 patients (76%) for analyses of restenosis at 1 year.
Stenosis on follow-up duplex scan was categorized as
50%, 50% to 70%, 70%, 70% to 80%, 80%, or occlu-
ion. We defined a clinically significant stenosis as 70%.
Statistical analysis. First, we examined univariate as-
ociations between individual patient characteristics and
he use of completion imaging with 2 and Fisher exact
ests. To gain insight into the patient-level factors associ-
ted with undergoing a completion imaging study, all
rotid endarterectomy (CEA) across surgeons.ariables with values of P  .20 were used to develop a
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August 2011378 Wallaert et almultivariate logistic regression model to predict which
patients were most likely to undergo completion imaging.
Next, we performed univariate comparisons with our
main outcome measures across each of the three categories
of surgeon practice pattern in completion imaging. The
30-day stroke/death rate was also analyzed independent of
practice pattern and reported in a distinct patient-level
analysis. This variable was analyzed in a categoric fashion.
Life-table analysis was used to calculate the incidence of
stenosis at 1-year follow-up. Kaplan-Meier survival curves
and log-rank tests were used to compare 1-year stenosis
rates across the three surgeon practice patterns.
To risk adjust rates of 30-day stroke/death, we used a
previously published logistic regression model that pre-
dicted the patient-level risk of 30-day stroke/death in the
VSGNE as described in our previous work.27 Covariates in
this model were used to determine the effect of surgeon
practice pattern on 30-day stroke/death rate, adjusted for
the patient characteristics known to be associated with
stroke or death. A similar Cox proportional hazards model
was constructed for stenosis at 1 year, using our previously
published model for risk factors associated with resteno-
sis.28 We purposefully included surgeon practice pattern,
independent of its significance, to allow us to discern its
effect on our main outcome measures. We also examined
surgeon volume and adjusted for variations in volume in
our multivariate analysis.
Operative report audits of re-exploration based on
completion imaging. To gain insight into what aspects of
completion imaging prompt re-exploration, as well as what
actions are taken during re-exploration, we sampled 90
operative reports from 178 patients who underwent re-
exploration from two institutions where these data were
available (operative records from the remaining institutions
were not available for analysis).
Findings on completion imaging were categorized in
five ways: (1) flap/debris/plaque, (2) thrombosis, (3) dis-
section, (4) increased/decreased velocity, or (5) other. We
then categorized the intervention undertaken for each case
as (1) tacking/removal of debris, (2) angiography with or
without endovascular intervention, or (3) other.
We then examined the effect of re-exploration in the
multivariable models described above on 30-day stroke or
death.
RESULTS
Demographics and use of completion imaging.
Overall, we studied 6115 CEAs, performed in 5638 patients
by 73 surgeons. Completion assessment of patency was per-
formed in 5554 CEAs (91%); however, in 3520 (58%) this
consisted only of Doppler insonation, and not completion
imaging, defined as duplex scanning or arteriography. Com-
pletion imaging was used in 2033 CEAs (33%) comprising
DUS imaging in 1919 (94%), arteriography in 94 (5%), and
both arteriography and DUS imaging in 20 (1%). Patient,
surgeon, and hospital characteristics were compared between
CEAs in which completion imaging was and was not per-
formed (Table I, A; Appendix Table I, online only).
cable I. A, Patient, surgeon, and hospital characteristics
ssociated with performing completion imaging (CI) after
arotid endarterectomy (CEA)a
ariable
CEA (N  6115)
Pb
CI No CI
No. (% total) No. (% total)
atient characteristics
Urgency
Elective 1845 (34) 3652 (66) .047
Urgent 169 (30) 403 (70)
Emergent 19 (44) 24 (56)
Ipsilateral degree of stenosis
50% 30 (67) 15 (33) .001
50% 62 (66) 32 (34)
60% 127 (49) 134 (51)
70% 384 (30) 909 (70)
80% 1402 (32) 2961 (68)
Occluded 17 (45) 21 (55)
Contralateral degree of
stenosis
50% 1117 (33) 2274 (67) .001
50% 196 (32) 417 (68)
60% 112 (20) 436 (80)
70% 239 (39) 379 (61)
80% 133 (34) 256 (66)
Occluded 134 (37) 224 (63)
Symptom status
Asymptomatic 1230 (32) 2655 (68) .001
TIA or stroke 802 (36) 1423 (64)
urgeon/operative
characteristics
Preoperative medication
regimen
No antiplatelet agent 190 (29) 475 (71) .001
Antiplatelet agent use
Aspirin only 1403 (32) 3055 (68)
Clopidogrel only 66 (36) 117 (64)
Aspirin and clopidogrel 372 (46) 428 (54)
Type of anesthesia
Local/regional anesthesia 172 (24) 539 (76) .001
General anesthesia 1861 (34) 3540 (66)
Use of intraoperative shunt
None 858 (27) 2334 (73) .001
Routine 1077 (41) 1516 (59)
For neurologic changes 98 (30) 229 (70)
Closure of CEA
Conventional, primary
closure 58 (16) 310 (84) .001
Conventional, with patch 1641 (32) 3457 (68)
Eversion endarterectomy 334 (52) 309 (48)
ospital characteristics
Center-specific ratesc
Center 1 27 (10) 239 (90) .001
Center 2 841 (49) 867 (51)
Center 3 2 (1) 407 (99)
Center 4 700 (92) 57 (8)
Center 6 325 (51) 308 (49)
Center 8 7 (2) 304 (98)
Center 9 0 (0) 606 (100)
Center 10 38 (4) 975 (96)
Center 12 60 (19) 260 (81)
IA, Transient ischemic attack.
Also see Appendix Table I, online only.
2Missing data not included in analysis, percentages reflect rows.
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Volume 54, Number 2 Wallaert et al 379Several patient-level and operative factors were associ-
ated with the use of completion imaging (Table I, B;
Appendix Table II, online only). This model had reason-
able discriminative ability (area under the receiver operat-
ing curve  0.72). Unfortunately, intraoperative factors
that may further delineate the decision to use completion
imaging are not contained in our data set and therefore
were not available for analysis.
Surgeon practice patterns. Of the 73 surgeons in our
study, 37 (51%) rarely, 16 (22%) selectively, and 20 (27%)
routinely used completion imaging (Fig 1). Although 54%
of CEAs were performed by the 37 surgeons who rarely
used completion imaging, 29% of CEAs were performed by
the 20 surgeons who routinely used completion imaging.
The 16 surgeons who selectively used completion imaging
performed 17% of CEAs in our study.
Surgeon volume during the study period was nearly
identical in the groups of surgeons classified as rare (mean,
Table I. B, Multivariate analysis of factors associated
with performing completion imaging after carotid
endarterectomy (CEA)a
Variable OR 95% CI P
Male 1.15 1.02-1.30 .022
Urgency .001
Elective Ref
Urgent 0.58 0.47-0.72 .001
Hypertension 1.21 1.01-1.46 .043
-Blockers 1.28 1.08-1.51 .004
Prior CABG or coronary
intervention 0.87 0.76-0.99 .040
Congestive heart failure 1.28 1.02-1.60 .033
Ipsilateral degree of stenosis .001
50% stenosis Ref
70% stenosis 0.30 0.15-0.59 .001
80% stenosis 0.29 0.15-0.58 .001
Contralateral degree of stenosis .001
50% stenosis Ref
60% stenosis 0.55 0.43-0.69 .001
Ipsilateral ocular symptomsb 1.27 1.07-1.50 .005
Preoperative medication regimen .001
No antiplatelet agent Ref
Antiplatelet agent use
Aspirin only 1.25 1.02-1.52 .033
Clopidogrel only 1.50 1.02-2.20 .041
Aspirin and clopidogrel 2.10 1.64-2.69 .001
Use of intraoperative shunt .001
No shunt Ref
Routine shunting 2.51 2.19-2.88 .001
Closure of CEA .001
Conventional, primary closure Ref
Conventional, patch 2.08 1.52-2.84 .001
Eversion endarterectomy 7.92 5.56-11.28 .001
Use of dextran 2.23 1.57-3.17 .001
Protamine 0.58 0.51-0.66 .001
Other monitoring 0.17 0.12-0.23 .001
Area under the curve  0.72
CABG, Coronary artery bypass grafting; CI, confidence interval; ICA,
internal carotid artery; OR, odds ratio.
aAlso see Appendix Table II (online only).
bTransient ischemic attack or stroke.90 cases per surgeon; range, 5-585) and routine (mean, 88; wange 5-378) and was lower in the selective group (mean,
0; range, 5-174). However, within each category of sur-
eon practice pattern, there was wide variation in individual
urgeon case volume. Because our main outcome measures
ccurred relatively infrequently, this limited our ability to
nalyze the effect of volume on 30-day stroke/death at the
ndividual surgeon level.
Association between surgeon practice pattern and
utcomes. Crude 30-day stroke/death rates were signifi-
antly lower among surgeons who selectively used comple-
ion imaging and were higher in surgeons who routinely
sed completion imaging (1.7% rarely, 1.2% selectively,
.4% routinely, P  .05; Table II). When we risk-adjusted
0-day stroke/death rates for patient characteristics known
o independently predict stroke/death, including age (70
ears), contralateral internal carotid artery occlusion, use of
ntiplatelet agent, presence of congestive heart failure,
mergency procedure, preoperative ipsilateral cortical
ymptoms,27 we found that the differences across surgeon
ractice patterns were not statistically significant, but still
emonstrated the same direction and magnitude of effect
or selective-use surgeons (odds ratio [OR], 0.75; 95%
onfidence interval [CI], 0.40-1.41; P  .366) and for
outine-use surgeons (OR, 1.42; 95% CI, .93-2.17; P 
106; Table III).
In our secondmain outcomemeasure, restenosis70%
t 1 year, crude differences across surgeon practice patterns
able II. Thirty-day stroke or death rate among
urgeons who rarely, selectively, or routinely use
ompletion imaging in carotid endarterectomy
ompletion imaging
ractice pattern
30-day stroke or death
No, No. (%)a Yes, No. (%)a Pb
are (5%) 3279/3334 (98.4) 55/3334 (1.7) .048
elective (5%-90%) 1006/1018 (98.8) 12/1018 (1.2)
outine (90%) 1721/1763 (97.6) 42/1763 (2.4)
P value from 2 test.
Refers to percentage of cases.
able III. Multivariate analysis of factors associated with
0-day stroke/death after carotid endarterectomy
ariable OR 95% CI P
ompletion study practice pattern .099
Rare (5%) Ref
Selective (5%-90%) 0.75 0.40-1.41 .366
Routine (90%) 1.42 0.93-2.17 .106
ge 70 years 2.05 1.33-3.15 .001
ontralateral ICA occlusion 2.56 1.41-4.66 .002
ntiplatelet agent use 0.60 0.35-1.01 .056
ongestive heart failure 1.40 0.74-2.65 .304
mergency procedure 0.98 0.13-7.35 .985
re-op ipsilateral cortical symptoms 2.44 1.63-3.65 .001
rea under the curve  0.70
I, Confidence interval; ICA, internal carotid artery; OR, odds ratio.ere not statistically significant (2.8% rarely, 1.1% selective,
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August 2011380 Wallaert et al1.1% routine, P  .09). However, Kaplan-Meier survival
curves demonstrated a trend toward a slightly lower risk of
restenosis among surgeons who performed selective or
routine completion imaging (Fig 2). Of all patients diag-
nosed with restenosis70% at 1 year, only four underwent
reintervention (repeat CEA or carotid stent) due to symp-
toms.
When we risk-adjusted 1-year restenosis rates for pa-
tient characteristics known to independently predict reste-
nosis, including type of closure (primary vs patched), con-
tralateral carotid artery stenosis, and dialysis,28 selective use
of completion imaging was associated with a significantly
lower risk of stenosis at 1 year, with a hazard ratio (HR) for
restenosis in selective-use compared to rare-use of 0.52
(95% CI, 0.29-.092, P  .024; Table IV). However, rou-
tine use of completion imaging had little effect on the risk
of restenosis, with an HR for restenosis in routine-use
compared to rare-use of 0.92 (95% CI, 0.61-1.38, P 
.676). As in our prior work, we confirmed that there are
significant associations between primary closure, contralat-
eral carotid artery stenosis, and restenosis.28
Re-exploration prompted by completion imaging
and operative report audit. Overall, intraoperative ca-
rotid artery re-exploration occurred in 178 CEAs, compris-
ing 2.9% of all CEAs and 8.8% of CEAs with completion
imaging. The rate of re-exploration was significantly higher
among routine-use surgeons compared with selective or
rare-use surgeons (7.6% routine, 0.8% selective, 0.9% rare,
P  .001 between routine/selective, P  .001 between
Fig 2. Kaplan-Meier plot shows proportion of patients
after carotid endarterectomy across surgeon practice patroutine/rare). Of the 31 patients who underwent re- axploration without completion imaging, 25 had Doppler
nsonation of the endarterectomy before re-exploration.
Of these 178 CEAs, we audited 90 available operative
eports from cases where re-exploration was prompted by
ndings on completion imaging. The most common finding
n completion imaging was flap/debris/plaque (77 of 90,
6%; Fig 3). Examples of these abnormalities are shown inFig4.
Operative findings at re-exploration. The most
ommon finding upon re-exploration was also flap/debris/
laque (67 of 88, 76%). In 10 of 88 patients (11%), however,
he abnormal completion imaging study represented a false
ositive, in that no identifiable technical defects were detected
n re-exploration. Two of these 10 patients underwent inter-
ention (additional tacking sutures) even though no discrete
from ipsilateral carotid artery restenosis (70%) 1 year
able IV. Multivariate Cox proportional hazards model
sed to predict restenosis rates at long-term follow-up
fter carotid endarterectomy
ariable HR 95% CI P
ompletion study practice pattern .078
Rare (5%) Ref
Selective (5%-90%) 0.52 0.29-0.92 .024
Routine (90%) 0.92 0.61-1.38 .676
rimary carotid closure 2.42 1.44-4.06 .001
ontralateral carotid stenosis 80% 1.90 1.08-3.31 .025
ialysis 1.90 0.26-13.66 .524
I, Confidence interval; HR, hazard ratio.freebnormality was found (Fig 3).
findings on re-exploration (right).
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 2 Wallaert et al 381Fig 4. Abnormalities discovered by intraoperative completion imaging after carotid endarterectomy. Panels 1 and 1a
show longitudinal and cross-sectional B-mode images from a patient undergoing completion duplex ultrasound
imaging which shows free-floating debris in the lumen of the internal carotid artery (ICA). Panel 2, Cross-sectionalIndication for Arterial  Re-exploration Intraoperative Findings on Re-exploration
Other, 1%
Nothing, 11%
Flow Velocity 
Abnormalities, 
2%
Other, 1%
Flow Velocity 
Abnormalities, 
7%
Dissection, 3%
Dissection, 5%
Thrombosis, 
5%
Thrombosis, 
3%
Intimal Flap / 
Debris / 
Residual 
Plaque,
86%
Intimal Flap / 
Debris / 
Residual 
Plaque,
76%
Fig 3. Indications for arterial re-exploration (n  90), as identified by completion imaging (left). IntraoperativeDoppler flow imaging in another patient reveals turbulent flow in the ICA due to rapidly accumulating thrombus.
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August 2011382 Wallaert et alOverall, 88 arteries were surgically re-explored, and 2
additional patients underwent arteriography and stent
placement without surgical re-exploration. In 79 of 90
re-explorations (88%) the intervention involved removing
or tacking excess debris/plaque. In 8 cases (9%), no inter-
vention was performed.
Thirty-day stroke or death in patients undergoing
re-exploration. Among the 178 patients who underwent
re-exploration, 6 strokes (3 minor, 3 major) and 1 death
occurred 30 days. These events were evenly distributed
across the categories of completion imaging findings.
Crude 30-day stroke/death rates were 3.9% in the 178
cases with arterial re-exploration compared with 1.7% in
those patients who were not re-explored (P .028). How-
ever, these differences were attenuated when we risk-
adjusted for patient characteristics predictive of 30-day stroke
or death (adjusted OR, 2.1; 95% CI, 0.9-5.0; P .076).
Effect of completion imaging on 30-day stroke or
death (patient level analysis). To investigate our pre-
sumption that completion imaging is used most commonly
in CEAs where stroke risk is higher, we compared the rates
of 30-day stroke/death between patients who underwent
completion imaging with those who did not. Crude 30-day
stroke/death rates were higher in patients where comple-
tion imaging is performed (2.6% vs 1.3%; P  .001).
Further, after adjusting for patient characteristics associated
with 30-day stroke/death, the odds of stroke/death re-
mained significantly higher in patients undergoing comple-
tion imaging (OR, 1.9; 95% CI, 1.2-2.7; P  .002),
suggesting that differences in outcome were not due to
differences in patient characteristics.
DISCUSSION
Surgeon practice pattern in the use of completion im-
aging varies widely across New England, and the use of
completion imaging is not associated with a significantly
lower risk of 30-day stroke or death. Rather, routine use of
completion imaging was associated with a trend toward a
higher risk-adjusted 30-day stroke/death, and selective use
was associated with a trend toward lower risk-adjusted
30-day stroke/death rates. Further, surgeons who selec-
tively use completion imaging have a significant reduction
in restenosis 1 year after surgery, although the absolute
effect size was small. Lastly, it remains uncertain whether
re-exploration based on completion imaging is associated
with higher rates of perioperative stroke/death, although
our results suggest that the risk of adverse outcomes are
higher in those patients who undergo re-exploration.
Completion imaging and stroke or death. Several
prior investigators have studied the relationship between
completion imaging and stroke/death after CEA (Table
V). In a 1997 study in a study of 9000 CEAs, Rockman
et al9 reported no significant difference in 30-day stroke/
death rates between patients undergoing completion imag-
ing and those who did not (3.6% vs 3.3%, respectively).
Studies by Dykes et al2 (1997) and Lipski et al5 (1995)
further support these findings. Moreover, Rockman et al9reported no difference in 30-day stroke/death rates be- aween surgeons whose use of completion imaging was
lassified as routine (90% of CEAs) and those who never
erformed completion imaging (2.9% vs 3.6%). These data
eflect our results, which demonstrated no statistically sig-
ificant difference in 30-day stroke/death across surgeon
ractice pattern in completion imaging. Instead, our find-
ngs suggest a trend toward increased risk of stroke or death
mong surgeons who routinely use completion imaging,
ven after adjusting for patient factors predictive of stroke
r death.
Our study specifically examined surgeons who selec-
ively use completion imaging. We hoped that this category
ight add insight into the effect of surgeon “judgment,”
nd indeed, crude and adjusted rates of stroke/death were
owest in this group. One might reason that routine use of
ompletion imaging may be overly sensitive and might
etect more defects than necessary, resulting in unnecessary
e-exploration and increased stroke risk. Our data offer
uggestive support for this theory: crude and adjusted
troke risks were highest among surgeons who routinely
erformed completion imaging, and these surgeons had
ignificantly higher rates of re-exploration.
Completion imaging and restenosis. Several prior
tudies have examined the relationship between comple-
ion imaging and stenosis after CEA (Table V).1-13,15-25
tudies by Dykes et al2 (1997) and Lipski et al5 (1995),
howed less residual stenosis in the immediate postopera-
ive period in cases using intraoperative completion imag-
ng, and Kinney et al18 (1993) reported significantly lower
ates of recurrent stenosis up to 48 months after surgery in
hose cases where completion imaging was performed. In
ur study, rates of 70% carotid artery stenosis at 1 year
fter CEA were significantly lower among surgeons who
electively use completion imaging. However, because we
id not collect data on immediate postoperative DUS
esults, our 1-year stenosis rate may reflect recurrent or
esidual stenosis, or both. Additionally, our follow-up ex-
ends only for 1 year, limiting application of our findings in
efining long-term restenosis.
Re-exploration and risk of stroke or death.
lthough completion imaging studies can identify correct-
ble technical defects,1,2,16,29 no standardized recommen-
ations presently exist to identify which lesions justify ca-
otid artery re-exploration and which are best left alone.
everal studies have demonstrated that not all lesions are
ssociated with an increased risk of perioperative complica-
ions and, thus, do not require immediate operative revi-
ion.3,4,30 However, most would agree that the correct
hresholds to inform the decision for intraoperative re-
xploration, except for in cases with extreme findings, have
et to be established.
Unfortunately, re-exploration itself might increase the
isk of stroke, possibly due to increased ischemic time or
ther manipulation during re-exploration. For example,
ne study by Zannetti et al10 showed that patients who
nderwent surgical revision as a result of completion imag-
ng findings actually experienced strikingly worse perioper-
tive neurologic outcomes. In our region, crude 30-day
n
e
c
t
o
t
p
e
o
p
C
fi
derate
f surge
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Volume 54, Number 2 Wallaert et al 383stroke/death rates were 3.9%, significantly higher in patients
who underwent re-exploration than in patients who did not
(1.7%), although this difference was attenuated with risk ad-
justment. Although this suggests that re-exploration itself
may be associated with a higher risk of stroke or death, it is
unknown what might have happened to these patients if
they had not been re-explored. It is reasonable to infer that
surgeons who re-explore patients do so because they be-
lieve the risk of stroke/death is higher if the technical
abnormality is not corrected.
Why not just compare completion imaging and no
completion imaging? Many will question why we simply
did not compare the risk of stroke/death between patients
Table V. Summary of representative studies from the liter
endarterectomy (CEA)
First author CEAs, No.
Abnormal
CI (%)
Ex
(%
Comparing CI vs no CI
Kinney (1993) 461 — 2
Lipski (1995) 86 —
Dykes (1997) 129 13 (20) 1
Rockman (2007) 9278 —
First author CEAs, (No.)
Abnormal
CI (%)
Ex
(%
Descriptive studies: All cases
used completion
imaging
Jernigan (1984) 603 . . . 1
Flanigan (1986) 155 43 (27.7) 1
Schwartz (1988) 84 18 (21.4)
Sawchuk (1989) 80 18 (22.5)
Baker (1994) 316 62 (19.6)
Hoff (1994) 44 22 (50)
Jain (1994) 455 . . .
Lohr (1995) 168 37 (28.2) 2
Papanicolaou (1996) 86 10 (11.6) 1
Walker (1996) 50 21 (42)
Ricotta (1997) 229 . . .
Westerbend (1997) 154 99 (64.3) 3
Steinmetz (1998) 100 13 (13)
Zannetti (1998) 1305 112 (9) 4
Seelig (1999) 115 29 (25.2) 1
Panneton (2001) 333 64 (41.3) 1
Pross (2001) 380 28 (7.5) 2
Mullenix (2003) 100 34 (34)
Ascher (2004) 650 . . . 1
Ott (2008) 74 33 (44.6)
AG, Intraoperative arteriogram; CI, completion imaging; IDS, intraoperativ
a50% stenosis on 2 or more successive duplex scans after surgery.
bRestenosis defined as 50% narrowing after at least 1 normal (50% steno
cRepresents all CEAs, including residual stenosis (discovered on postopera
months); defined as 75%.
dRestenosis defined as 50% by 12 months after CEA.
eEvidence of ICA stenosis on last scan (mean follow-up 9.2  7.3 months)
fNo cases of clinically significant restenosis (defined as 70%) were identifie
gRestenosis at 6 months: 14 patients had mild restenosis (60%); 2 had mo
hRestenosis/recurrent stenosis between 50% to total occlusion from time owho underwent completion imaging and those who did cot. We reasoned that cases involving completion imaging,
specially among selective users, likely represent technically
hallenging operations, wherein the surgeon chose to in-
errogate the repair using completion imaging. Although
ur risk adjustment can account for some proportion of
hese excess patient-level risks, there remains a significant
ossibility that confounding by indication may be pres-
nt.31 Therefore, we focused on the exposure variable in
ur study, surgeon practice pattern.
However, little is known about what conditions
rompt surgeons to perform completion imaging during
EA. Further, it remains unclear what completion imaging
ndings should prompt re-exploration, and which findings
on completion imaging (CI) after carotid
tion
ged)
30-day stroke or death
CI: No CI
(significance)
Restenosis
CI: No CI (significance)
) 2.6%/0 (NR) 24%:8%a (P  .0006)
.1) 1 (2.6%):2 (4.3%) (NS) 2 (5.1%):2 (4.3%)b (NS)
.8) 3 (2.3%):4 (6.2%) (NS) 3 (4.7%):2 (3.1%)b
4.3%:3.8% (NS) —
tion
ged)
30-day stroke or
death (%) Restenosis (%)
) 21 (3.4) . . .
7/145 (4.8) . . .
.7) 1 (1) . . .
3 (3.8) Normal IDS: 35% restenosis; mild
defects on IDS: 0% restenosis
) 7 (2.2) 14 (4.4)c
4 (9.1) 12 (27.3)d
13 (2.9) . . .
.6) 4 (3.1) . . .
.6) 0 0d
) 1 (2) . . .
.5) 7 (3.1) . . .
.8) 4 (2.6) . . .
) 4 (4) 11/88 (12.5)e
) 27 (2.1) . . .
.2) 0 0f
) 5 (3.2) . . .
) 4 (1) 16 (4.4)g
3 (3) 10 (10)d
) 5 (0.8) . . .
.8) 1 (1.4) 10 (13.5)h
lex surveillance; NR, not reported; NS, not significant.
uplex scan.
y 1), as well as recurrent stenosis (between 6 and 90 months, mean 21.6
h 50%, 5 with 50%.
year after CEA; 12 patients developed moderate restenosis of 40% to 69%.
restenosis (60%-79%).
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plora
of ima
6 (6.3
9 (23
2 (18
—
plora
of ima
5 (2.5
1 (7)
9 (10
0
9 (2.8
0
. . .
3 (17
0 (11
3 (6.0
3 (37
2 (20
2 (2.0
8 (3.7
4 (12
4 (9.0
4 (6.3
7 (7)
5 (2.3
8 (10
e dup
sis) d
tive da
; 6 wit
d 1an be managed conservatively. Our study showed that
z
a
A
C
A
D
W
C
F
S
O
O
R
1
1
1
1
1
JOURNAL OF VASCULAR SURGERY
August 2011384 Wallaert et alsurgeons who routinely use completion imaging are signif-
icantly more likely to perform re-exploration, and this
suggests that routine-use surgeons are either finding more
significant defects than selective-use or rare-use surgeons or
have a lower threshold for intervention. Our future work
will seek to identify those settings wherein completion
imaging will be most likely to identify only those lesions
that necessitate operative revision, without being “too sen-
sitive” and prompting unnecessary re-exploration.10
Limitations. Our study has several limitations. First,
data in the VSGNE reflect observational data, not evidence
from a randomized trial, and certain elements and details
surrounding patient events, such as the timing and extent
of stroke or operative indications for re-exploration, are
limited.
Second, practice patterns across the VSGNE are not
standardized. Thus, decisions such as when to perform
completion imaging and when to re-explore the carotid
artery likely vary across centers as well as among individual
surgeons, introducing potential selection bias.
Third, variation in surgeon practice pattern over time is
a possibility. However, when we examined the individual
surgeons in the selective use of completion imaging cate-
gory, we found that only 6% moved across categories,
indicating that surgeons who fall in the 5% to 90% range are
truly selecting when to perform completion imaging and
when it is not necessary based on various personal thresh-
olds and indications.
Fourth, althoughwe recognize that the descriptive data
pertaining to re-exploration are limited by the fact that only
half of re-explored patients were included in our chart
review, all quantitative analyses included every re-explored
patient in our cohort.
Fifth, DUS criteria for restenosis, either at the time of
completion imaging or at follow-up, varied across institu-
tions. However, these criteria did not change over time,
limiting any bias introduced to within-center variability,
with no changes across centers or over time.
CONCLUSIONS
Although completion imaging studies identify correct-
able technical lesions after CEA, there is little evidence to
suggest that surgeons who routinely or selectively use com-
pletion imaging have lower rates of 30-day stroke or death.
However, our study demonstrates that surgeons who selec-
tively use completion imaging have a trend toward lower
rates of 30-day stroke or death, and a small, but a statisti-
cally significant reduction in stenosis at 1 year after CEA.
Lastly, it remains uncertain whether or not re-exploration
based on completion imaging is associated with higher rates
of perioperative stroke or death, although our study sug-
gests that the risks of adverse outcomes are higher in those
patients who undergo re-exploration.
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August 2011385.e1 Wallaert et alAppendix Table I (online only). Patient, surgeon, and hospital characteristics associated with performing completion
imaging (CI) after carotid endarterectomy (CEA)
Variable
CEA (n  6115)
Pa
CI
No./row total (%)
No CI
n/row total (%)
Patient characteristics
Male gender 1254/3667 (34.2) 2413/3667 (65.8) .056
Right side 995/3020 (32.95) 2025/3020 (67.05) .605
White race 2012/6039 (33.32) 4027/6039 (66.68) .174
Non-white race 15/60 (25) 45/60 (75)
Urgency
Elective 1845/5497 (33.56/90.75) 3652/5497 (66.44/89.53) .047
Urgent 169/572 (29.55/8.31) 403/572 (70.45/9.88)
Emergent 19/43 (44.19/0.93) 24/43 (55.81/0.59)
Age, years
40 1/4 (25/0.05) 3/4 (75/0.07) .860
40-49 46/145 (31.72/2.26) 99/145 (68.28/2.43)
50-59 263/758 (34.7/12.94) 495/758 (65.3/12.14)
60-69 622/1892 (32.88/30.6) 1270/1892 (67.12/31.14)
70-79 784/2339 (33.52/38.56) 1555/2339 (66.48/38.12)
80-89 308/937 (32.87/15.15) 629/937 (67.13/15.42)
90 9/37 (24.32/0.44) 28/37 (75.68/0.69)
Smoking (prior or current) 1618/4876 (33.18) 3258/4876 (66.82)
Diabetes
No diabetes 1434/4243 (33.8/70.57) 2809/4243 (66.2/68.86) .197
Non-insulin–dependent diabetes 427/1367 (31.24/21.01) 940/1367 (68.76/23.04)
Insulin-dependent diabetes 171/501 (34.13/8.42) 330/501 (65.87/8.09)
Creatinine 1.8% 103/338 (30.47) 235/338 (69.53)
Dialysis 17/41 (41.46) 24/41 (58.54)
Hypertension 1807/5320 (33.97) 3513/5320 (66.03)
-Blockers 1732/5044 (34.34) 3312/5044 (65.66)
Coronary disease 683/2003 (34.1) 1320/2003 (65.9)
Prior CABG or coronary intervention 628/1944 (32.3) 1316/1944 (67.7)
Congestive heart failure 165/450 (36.67) 285/450 (63.33)
Ipsilateral degree of stenosis
50% 30/45 (66.67/1.48) 15/45 (33.33/0.37) .001
50% 62/94 (65.96/3.07) 32/94 (34.04/0.79)
60% 127/261 (48.66/6.28) 134/261 (51.34/3.29)
70% 384/1293 (29.7/18.99) 909/1293 (70.3/22.32)
80% 1402/4363 (32.13/69.34) 2961/4363 (67.87/72.72)
Occluded 17/38 (44.74/0.84) 21/38 (55.26/0.52)
Contralateral degree of stenosis
50% 1117/3391 (32.94/57.85) 2274/3391 (67.06/57.05) .001
50% 196/613 (31.97/10.15) 417/613 (68.03/10.46)
60% 112/548 (20.44/5.8) 436/548 (79.56/10.94)
70% 239/618 (38.67/12.38) 379/618 (61.33/9.51)
 80% 133/389 (34.19/6.89) 256/389 (65.81/6.42)
Occluded 134/358 (37.43/6.94) 224/358 (62.57/5.62)
Symptom status
Asymptomatic 1230/3885 (31.66) 2655/3885 (68.34) .001
TIA or stroke 802/2225 (36.04) 1423/2225 (63.96)
Ipsilateral cortical symptoms
Asymptomatic 1525/4624 (32.98) 3099/4624 (67.02) .409
TIA or stroke 508/1488 (34.14) 980/1488 (65.86)
Ipsilateral ocular symptoms
Asymptomatic 1704/5246 (32.48) 3542/5246 (67.52) .001
TIA or stroke 329/864 (38.08) 535/864 (61.92)
Vertebrobasilar symptoms
Asymptomatic 1971/5958 (33.08) 3987/5958 (66.92) .069
TIA or stroke 61/152 (40.13) 91/152 (59.87)
Preoperative medication regimen
No antiplatelet agent 190/665 (28.57/9.35) 475/665 (71.43/11.66) .001
Antiplatelet agent use
Aspirin only 1403/4458 (31.47/69.08) 3055/4458 (68.53/74.97)
Clopidogrel only 66/183 (36.07/3.25) 117/183 (63.93/2.87)
Aspirin and clopidogrel 372/800 (46.5/18.32) 428/800 (53.5/10.5)Preoperative statin use 1485/4506 (32.96) 3021/4506 (67.04)
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Variable
CEA (n  6115)
Pa
CI
No./row total (%)
No CI
n/row total (%)
Prior radiation therapy 23/65 (35.38) 42/65 (64.62)
Surgeon/operative characteristics
Type of anesthesia
Local/regional 172/711 (24.19) 539/711 (75.81) .001
General 1861/5401 (34.46) 3540/5401 (65.54)
Intraoperative shunt use
None 858/3192 (26.88/42.2) 2334/3192 (73.12/57.22) .001
Routine 1077/2593 (41.53/52.98) 1516/2593 (58.47/37.17)
For neurologic changes (indication) 98/327 (29.97/4.82) 229/327 (70.03/5.61)
Closure of CEA (any patch)
Conventional, primary closure 58/368 (15.76/2.85) 310/368 (84.24/7.61) .001
Conventional, with patch 1641/5098 (32.19/80.72) 3457/5098 (67.81/84.81)
Eversion endarterectomy 334/643 (51.94/16.43) 309/643 (48.06/7.58)
Dextran administered 72/274 (26.28) 202/274 (73.72)
Protamine administered 871/2880 (30.24) 2009/2880 (69.76)
Intraoperative monitoring
Awake 152/662 (22.96) 510/662 (77.04)
Stump pressure 30/124 (24.19) 94/124 (75.81)
EEG 822/2779 (29.58) 1957/2779 (70.42)
Other 61/591 (10.32) 530/591 (89.68)
Hospital characteristics
Center-specific ratesb (volume 175)
Center 1 27/266 (10.15/1.35) 239/266 (89.85/5.94) .001
Center 2 841/1708 (49.24/42.05) 867/1708 (50.76/21.55)
Center 3 2/409 (0.49/0.1) 407/409 (99.51/10.12)
Center 4 700/757 (92.47/35) 57/757 (7.53/1.42)
Center 6 325/633 (51.34/16.25) 308/633 (48.66/7.66)
Center 8 7/311 (2.25/0.35) 304/311 (97.75/7.56)
Center 9 0/606 (0/0) 606/606 (100/15.06)
Center 10 38/1013 (3.75/1.9) 975/1013 (96.25/24.24)
Center 12 60/320 (18.75/3) 260/320 (81.25/6.46)
CABG, Coronary artery bypass grafting; EEG, electroencephalogram; TIA, transient ischemic attack.
a 2P value from  test.
bMissing data not included in analysis; percentages reflect rows.
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carotid endarterectomy
Variable OR 95% CI P
Male 1.15 1.02-1.30 .022
Urgency .001
Elective Ref
Urgent 0.58 0.47-0.72 .001
Emergent 1.38 0.71-2.71 .343
Hypertension 1.21 1.01-1.46 .043
-Blockers 1.28 1.08-1.51 .004
Prior CABG or coronary intervention 0.87 0.76-0.99 .040
Congestive heart failure 1.28 1.02-1.60 .033
Ipsilateral degree of stenosis .001
50% Ref
50% 1.14 0.50-2.56 .760
60% 0.64 0.31-1.33 .230
70% 0.30 0.15-0.59 .001
80% 0.29 0.15-0.58 .001
Occluded 0.54 0.20-1.46 .226
Contralateral degree of stenosis .001
50% Ref
50% 0.89 0.74-1.09 .265
60% 0.55 0.43-0.69 .001
70% 1.21 1.00-1.46 .054
80% 1.00 0.79-1.27 .996
Occluded 1.08 0.84-1.38 .542
Ipsilateral ocular symptoms (TIA or stroke) 1.27 1.07-1.50 .005
Preoperative medication regimen .001
No antiplatelet agent Ref
Antiplatelet agent use
Aspirin only 1.25 1.02-1.52 .033
Clopidogrel only 1.50 1.02-2.20 .041
Aspirin and clopidogrel 2.10 1.64-2.69 .001
Use of intraoperative shunt .001
None Ref
Routine 2.51 2.19-2.88 .001
Neurologic changes (indication) 1.27 0.95-1.68 .103
Closure of CEA .001
Conventional, primary closure Ref
Conventional, with patch 2.08 1.52-2.84 .001
Eversion endarterectomy 7.92 5.56-11.28 .001
Use of dextran 2.23 1.57-3.17 .001
Protamine 0.58 0.51-0.66 .001
Other monitoring 0.17 0.12-0.23 .001
Area under the curve  0.72CABG, Coronary artery bypass grafting; CI, confidence interval; OR, odds ratio; TIA, transient ischemic attack.
